XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity - Summary of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Number of Outstanding Options, Beginning balance | shares 7,345,444  
Number of Outstanding Options, Granted | shares 1,984,650  
Number of Outstanding Options, Exercised | shares (191,879)  
Number of Outstanding Options, Forfeited or cancelled | shares (642,634)  
Number of Outstanding Options, Ending balance | shares 8,495,581 7,345,444
Number of Outstanding Options, Vested and expected to vest | shares 8,495,581  
Number of Outstanding Options, Exercisable | shares 5,413,688  
Weighted- Average Exercise Price, Beginning balance | $ / shares $ 11.67  
Weighted- Average Exercise Price, Granted | $ / shares 13.90  
Weighted- Average Exercise Price, Exercised | $ / shares 8.65  
Weighted- Average Exercise Price, Forfeited or cancelled | $ / shares 13.71  
Weighted- Average Exercise Price, Ending balance | $ / shares 12.10 $ 11.67
Weighted- Average Exercise Price, Vested and expected to vest | $ / shares 12.10  
Weighted- Average Exercise Price, Exercisable | $ / shares $ 9.72  
Weighted- Average Remaining Contractual Term 7 years 7 months 6 days 8 years 3 months 21 days
Weighted- Average Remaining Contractual Term, Vested and expected to vest 7 years 7 months 6 days  
Weighted- Average Remaining Contractual Term, Exercisable 7 years 1 month 2 days  
Aggregate Intrinsic Value | $ $ 15,076 $ 29,806
Aggregate Intrinsic Value, Vested and expected to vest | $ 15,076  
Aggregate Intrinsic Value, Exercisable | $ $ 14,999